Market News & Trends
Allergan Acquires LiRIS Program From TARIS Biomedical
Allergan Inc. and TARIS Holdings LLC recently announced that Allergan has closed a transaction to acquire worldwide rights to TARIS Biomedical’s lead program, LiRIS, which…
Pharmacogenetic Testing Company Launches Robust Drug Testing Program
Pinnacle Laboratory Services has successfully launched one of the most comprehensive Pharmacogenetic programs available on the market. Pinnacle Laboratory Services specializes in Pharmacogenetic testing with…
Optibrium Launches New Software for Compound Data Visualization
Optibrium recently announced the launch of Sentira, a new desktop application that provides dynamic data visualization and analysis of compound data. Applicable across all fields…
Ashland Commits to Major Capacity Expansion to Meet Customer Demand
Ashland Specialty Ingredients, a commercial unit of Ashland Inc. recently announced plans to significantly expand production capacity of its Klucel hydroxypropylcellulose (HPC) product line in…
Charleston Laboratories & Daiichi Sankyo Announce Major Collaboration
Charleston Laboratories, Inc., through its wholly owned subsidiary LOCL Pharma, Inc., and Daiichi Sankyo recently announced the parties have entered into a strategic collaboration for…
Sanofi & MannKind Announce Global Licensing Agreement
Sanofi and MannKind Corporation recently announced they have entered into a worldwide exclusive licensing agreement for development and commercialization of Afrezza (insulin human) Inhalation Powder,…
Immune Response BioPharma to Develop In-House Sales Force for Blockbuster Vaccine
New Jersey-based Immune Response BioPharma, Inc. recently announced its plans to create an in-house sales force for Remune, its HIV vaccine. Remune is a therapeutic…
Mexico’s Healthcare Market Value to Reach Almost $28 Billion by 2020, says GlobalData
LONDON, UK (GlobalData), 7 August 2014 - Mexico’s pharmaceutical and medical devices industries will be worth approximately $22.5 billion and $5.4 billion by 2020, respectively,…
ZIOPHARM Oncology & Solasia Pharma Announce Global License & Collaboration Agreement
ZIOPHARM Oncology & Solasia Pharma Announce Global License & Collaboration Agreement ZIOPHARM Oncology, Inc. and Solasia Pharma K.K. recently announced an amendment and restatement of…
Allied Minds & Bristol-Myers Squibb Form New Enterprise
Allied Minds & Bristol-Myers Squibb Form New Enterprise Allied Minds and Bristol-Myers Squibb Company recently announced the formation of Allied-Bristol Life Sciences LLC, a new…
Lubrizol Acquires Leading Manufacturer in Global Device Industry
The Lubrizol Corporation recently announced it has acquired Vesta, a leading contract manufacturer for the global medical device industry. This acquisition broadens Lubrizol's life science…
ACS Treatment Market to More Than Triple From $12.3 Billion to $43.4 Billion
The launch of several drugs with “extraordinary blockbuster potential” will cause the acute coronary syndrome (ACS) treatment market to more than triple in value, from…
Ready-to-Use EZ-Fit Filtration Unit From EMD Millipore Leverages Industry Leading Technology
EMD Millipore has launched the EZ-Fit Filtration Unit, a ready-to-use, disposable filtration device for bioburden testing. The system is more efficient than traditional methods, resulting…
Harlan Provides Expertise for Biologics & Biosimilars
Harlan Laboratories, Ltd. is prepared to meet the global demand for development programs in novel biologics and biosimilars. While the US FDA is slower to…
ACS Treatment Market to More Than Triple From $12.3 Billion to $43.4 Billion
The launch of several drugs with “extraordinary blockbuster potential” will cause the acute coronary syndrome (ACS) treatment market to more than triple in value, from…
Specialty Vaccine Company PaxVax Secures Up to $60 Million in Financing
PaxVax, Inc., a specialty vaccine company focused on travel and biodefense, recently announced it has closed up to $50 million in secured debt financing from…
Bristol-Myers Squibb to Expand, Build Cancer Research Hub
Bristol-Myers Squibb Co. recently announced it has taken the first steps toward expanding its office space and building a cancer research hub for drugs that…
Horizon Discovery & Otsuka Sign Collaboration Agreement
Horizon Discovery Group plc recently announced its Horizon CombinatoRx division has been contracted by Otsuka Pharmaceutical Development and Commercialization, Inc. (OPDC) to perform in vitro…
Capsugel Study Provides First Substantive Reference Data on Key Quality Attributes of Empty Capsules
Capsugel recently published a study in AAPS’ PharmSciTech journal confirming that Capsugel capsules are suitable excipients for Quality-by-Design (QbD)-based product development and manufacturing. The study…
